Uros Gregorc PhD

Dr. Uros Gregorc received his PhD in Biomedical Sciences at the University of Ljubljana in 2005. He did his studies at the Department of Biochemistry and molecular biology at Jozef Stefan Institute and also spent some time as an exchange student in prof. Salvesen’s lab at the Burnham Institute, La Jolla, and prof. Bank’s lab at the ICGEB, Trieste.

He has joined Lek Pharmaceuticals (part of Sandoz Biopharmaceuticals) in 2006 and is now a Senior Scientist in the Downstream process development group. At their current position, his work is mainly focused on the development of industrial downstream processes for the recombinant proteins, mostly monoclonal antibodies. Part of his work is dedicated to the evaluation of novel technologies in downstream processing. He is also involved in the implementation of the Quality by Design (QbD) principles in the downstream process development, characterization, and validation.